150 related articles for article (PubMed ID: 3224080)
1. Sensitivity of locally recurrent rat mammary tumour cell lines to syngeneic polymorphonuclear cell, macrophage and natural killer cell cytolysis.
Aeed PA; Welch DR
Br J Cancer; 1988 Dec; 58(6):746-52. PubMed ID: 3224080
[TBL] [Abstract][Full Text] [Related]
2. Experimental model for locally recurring mammary tumors. Development, morphology, karyotype, growth kinetics, and experimental metastatic potential.
Estrada J; Freeman DL; Aeed PA; Welch DR
Cancer; 1989 Apr; 63(7):1353-62. PubMed ID: 2920363
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity in the sensitivities of the 13762NF rat mammary adenocarcinoma cell clones to cytolysis mediated by extra- and intratumoral macrophages.
North SM; Nicolson GL
Cancer Res; 1985 Apr; 45(4):1453-8. PubMed ID: 3978611
[TBL] [Abstract][Full Text] [Related]
4. Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas.
Welch DR; McClure SA; Aeed PA; Bahner MJ; Adams LD
Clin Exp Metastasis; 1990; 8(6):533-51. PubMed ID: 2225568
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a rat model for locally recurring mammary tumors: sensitivities to 5-fluoro-2'-deoxyuridine, adriamycin, and X-irradiation.
Welch DR; Aeed PA; Estrada J
Cancer Res; 1988 Aug; 48(16):4549-54. PubMed ID: 2969281
[TBL] [Abstract][Full Text] [Related]
6. Effect of host immune status on the spontaneous metastasis of cloned cell lines of the 13762NF rat mammary adenocarcinoma.
North SM; Nicolson GL
Br J Cancer; 1985 Nov; 52(5):747-55. PubMed ID: 4063149
[TBL] [Abstract][Full Text] [Related]
7. Tumour cells in metastatic deposits with altered sensitivity to natural killer cells.
Brooks CG; Flannery GR; Willmott N; Austin EB; Kenwrick S; Baldwin RW
Int J Cancer; 1981 Aug; 28(2):191-8. PubMed ID: 7319671
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of murine mammary adenocarcinoma cell subpopulations. In vitro and in vivo resistance to macrophage cytotoxicity and its association with metastatic capacity.
Yamamura Y; Fischer BC; Harnaha JB; Proctor JW
Int J Cancer; 1984 Jan; 33(1):67-72. PubMed ID: 6693196
[TBL] [Abstract][Full Text] [Related]
9. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
10. A functional comparison of tumor cell killing by activated macrophages and natural killer cells.
Roder JC; Lohmann-Matthes ML; Domzig W; Kiessling R; Haller O
Eur J Immunol; 1979 Apr; 9(4):283-8. PubMed ID: 467492
[TBL] [Abstract][Full Text] [Related]
11. Quantitative studies of natural immunity to solid tumours in rats. NK activity in animals with primary or transplanted spontaneous tumours.
Flannery GR; Brooks CG
Int J Cancer; 1981 Dec; 28(6):747-55. PubMed ID: 7333706
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.
Vujanovic NL; Herberman RB; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):878-83. PubMed ID: 3257411
[TBL] [Abstract][Full Text] [Related]
13. The effect of interferon-gamma treatment of rat tumour cells on their susceptibility to natural killer cell, macrophage and cytotoxic T-cell killing.
Yeoman H; Robins RA
Immunology; 1988 Feb; 63(2):291-7. PubMed ID: 2965096
[TBL] [Abstract][Full Text] [Related]
14. Alterations in sensitivity to nonspecific cell-mediated lysis associated with tumor progression: characterization of activated macrophage- and natural killer cell-resistant tumor variants.
Nestel FP; Casson PR; Wiltrout RH; Kerbel RS
J Natl Cancer Inst; 1984 Aug; 73(2):483-91. PubMed ID: 6589440
[TBL] [Abstract][Full Text] [Related]
15. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
Sheil JM; Gallimore PH; Zimmer SG; Sopori ML
J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497
[TBL] [Abstract][Full Text] [Related]
16. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
Zöller M; Matzku S
Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
[TBL] [Abstract][Full Text] [Related]
17. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
[TBL] [Abstract][Full Text] [Related]
18. Two-step mechanism of macrophage-mediated tumor lysis in vitro.
Yamazaki M; Shinoda H; Suzuki Y; Mizuno D
Gan; 1976 Oct; 67(5):741-5. PubMed ID: 797628
[TBL] [Abstract][Full Text] [Related]
19. Effect of tunicamycin on sialomucin and natural killer susceptibility of rat mammary tumor ascites cells.
Bharathan S; Moriarty J; Moody CE; Sherblom AP
Cancer Res; 1990 Sep; 50(17):5250-6. PubMed ID: 2386935
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cell infiltrate associated with primary and transplanted tumours in an inbred model of oral carcinogenesis.
Thomas DW; Matthews JB; Patel V; Game SM; Prime SS
J Oral Pathol Med; 1995 Jan; 24(1):23-31. PubMed ID: 7536846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
